Objective. The development of obesity and its metabolic complications is associated with dysregulation of various intrinsic mechanisms, which control basic metabolic processes through changes in the expression of numerous regulatory genes.
al. 2012; Han and Kaufman 2014; Lee and Ozcan 2014; Cajander et al. 2016) . Special interest deserves the key factors, which control immune response as well as many other processes including cell proliferation (Schaiff et al. 1992; Nair et al. 2005; Kochan et al. 2013; Carosella et al. 2015; Wang et al. 2015 Boegel et al. 2018; Farjadian et al. 2018; Wu et al. 2017 Wu et al. , 2018 .
For this investigation following genes were selected: HLA-DRA (major histocompatibility complex, class II, DR alpha), HLA-DRB1 (major histocompatibility complex, class II, DR alpha), HLA-G (major histocompatibility complex, class I, G), HLA-F (major histocompatibility complex, class I, F), and NFX1 (nuclear transcription factor, X-box binding 1) as well as micro RNA miR-190b. The HLA-DRA and HLA-DRB1 genes encode the alpha and beta1 subunits of HLA-DR receptor, which create a heterodimer. Both subunits anchored in the membrane and their co-regulated expression is mediated by the MHCII RNA operon and is controlled by FOXP1 as well as NFX1 (Song et al. 1994; Pisapia et al. 2013; Brown et al. 2016) . Its primary role in immune response is presenting peptides derived from extracellular proteins. Furthermore, a reduction in HLA-DR gene expression, which is observed in cancer and in sepsis, correlates with an impaired TNFα response (Cajander et al. 2013; Leite et al. 2014; Winkler et al. 2017 ). The HLA-DRA mediates effects of insulin, insulinlike growth factor 1, and other cytokines by acting as a molecular adaptor between diverse receptor tyrosine kinases and downstream effectors through phosphorylation by the insulin receptor tyrosine kinase upon receptor stimulation as well as other kinases (Wu et al. 2017) . It is interesting to note that in the proximal promoter of major histocompatibility complex (MHC) class II genes there is regulatory element, which sequence-specifically interacts with the conserved X1 box found in DNA binding protein NFX1, a cysteine-rich polypeptide, and regulates the expression of MHC class II molecules. There is data that overexpression of NFX1, which is a transcriptional repressor of MHC class II molecules, strongly and specifically represses the transcription of the HLA-DRA gene in MHC class II positive cell lines (Song et al. 1994) . Furthermore, there is data that this transcription factor also participates in mammalian mRNA export as well as in TERT mRNA expression binds to the X-box motif of this gene promoter (Li and Noegel 2015; Yamashita et al. 2016) .
The non-classical HLA-class I molecule G (human leukocyte antigen HLA-G) is a heterodimer consisting of a heavy chain and a light chain, which is involved in the presentation of foreign antigens to the immune system as well as in the susceptibility to cervical squamous cell carcinoma and other tumors (Yang et al. 2014; Zeestraten et al. 2014; Walentowicz-Sadlecka et al. 2018) . Moreover, HLA-G when expressed by a tumor protects it from antitumor immunity (Carosella et al. 2015) . It is interesting to note that alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens (Ishitani and Geraghty 1992) . There is data that HLA-G expression is associated with poor survival in stage III gastric cancer patients and represents a possible immunoescape mechanism of cancer cells (Murdaca et al. 2018) . At the same time, there are two opposite sides of HLA-G function: beneficial to be promoted or deleterious to be blocked (Amiot et al. 2015; Carosella et al. 2015) . Furthermore, the dual role of HLA-G in solid and liquid tumors was shown: HLA-G inhibits the proliferation of malignant B cells due to the interaction between HLA-G and its receptor ILT2, which mediates negative signaling on B cell proliferation (Rouas-Freiss et al. 2014 ). Recently, it was shown that there is a strong association between HLA-G 14 bp ins/ins genotype and insulin resistance (evaluated by homeostasis model assessment [HOMA] ) in obese children and adolescents (Marzuillo et al. 2018) .
Human leukocyte antigen HLA-F is a non-classical HLA-class I molecule with immunosuppressive properties. The overexpression of HLA-F in islet cells is a hallmark in the immunopathogenesis of type 1 diabetes (Richardson et al. 2016) . Islet hyperexpression of HLA class I molecules occurred in the insulin-containing islets of patients with recentonset type 1 diabetes and was also detectable in many patients with disease duration of up to 11 years, declining thereafter. Moreover, expression of HLA-F is correlated with tumor cell invasion and metastasis Ishigami et al. 2015) . HLA-F expression was found to be enhanced in gastric adenocarcinoma, breast cancer, esophageal squamous cell carcinoma, hepatocellular carcinoma, and neuroblastoma Morandi et al. 2013; Harada et al. 2015; Martinez-Canales et al. 2017; Wu et al. 2018) .
The endoplasmic reticulum stress is also recognized as an important determinant of obesity, insulin resistance, and impaired glucose tolerance and contributes to the expression profile of many regulatory genes resulting in peripheral insulin resistance as well as other obesity complications (Ozcan et al. 2004; Wang and Kaufman 2012; Lee and Ozcan 2014; Hassler et al. 2015; Doultsinos et al. 2017; Wu et al. 2018) , although detailed molecular mechanisms cannot be ruled out. Activation of the endoplasmic reticulum stress sensors leads to transcriptional reprogramming of the cells, but inhibition of IRE1 mediated signaling pathway of endoplasmic reticulum stress affects the expression of numerous genes including insulin receptor and its substrates (IRS1 and IRS2), INSIG1 and INSIG2, insulin-like growth factors and IGF binding protein as well as proliferation related factors, estrogen and glucocorticoid related proteins (Auf et al. 2013; Chevet et al. 2015; Minchenko et al. 2013 Minchenko et al. , 2015a Minchenko et al. , 2015b Minchenko et al. , 2016a Minchenko et al. , 2016b Minchenko et al. , 2017 .
It is possible that clarification of real molecular mechanisms of metabolic disturbances in associated with obesity insulin resistance helps to better understanding why only a part of the obese individuals develops secondary metabolic disorders including resistance to insulin. However, a detailed molecular mechanism of the involvement of different genes of regulatory network in the development of insulin resistance and dysregulation of immune response in obese adolescents with insulin resistance remains unclear and deserves further investigation.
The main goal of this study was to clarify the role of the expression of a subset of genes, encoding for important immune response factors (HLA-DRA, HLA-DRB1, HLA-F, HLA-G, and NFX1) as well as microRNA miR-190b, in blood of obese adolescents with and without insulin resistance for evaluation of its probable significance in immune response in relation to obesity associated resistance to insulin.
Materials and methods
Patients' clinical characteristics. The 21 adolescents participate in this study. They were divided into three equal groups (7 subjects in each group): one group of relative healthy individuals without signs of obesity as control and two groups of obese patients: with and without insulin resistance. All participants gave written informed consent and the studies were approved by the local research ethics committees of Institute of Children and Adolescent Health Care of the National Academy of Medical Science of Ukraine.
Clinical characteristics of the study participants are shown in Table 1 . The participants of control group were relative healthy individuals with mean age 14.2±0.584 years and mean body mass index (BMI) 18.8±0.17 kg/m 2 . The obese participants without signs of insulin resistance had a mean age 13.8±0.265 years and a mean BMI 31.1±0.36 kg/m 2 . The group of obese patients with insulin resistance was individuals with mean age 14.5±0.297 years and BMI 34.3±1.72 kg/m 2 . Thus, BMI, which is a main criterion of obesity, in both groups of obese patients was significantly higher (+66 in a group without signs of insulin resistance and +83% in a group with insulin resistance; p<0.01 in both cases) as compared to control individuals (Table 1) . Furthermore, no significant changes were found in insulin resistance index evaluated by homeostasis model assessment (HOMA) in obese individuals as compared to relative healthy control group, but in obese patients with impaired insulin sensitivity the insulin resistance index was significantly increased as compared to control as well as to obese subjects with not changed insulin sensitivity (+258% and 225%, correspondingly; p<0.001 in both cases) ( Table 1) . The fasting insulin level did not significant changed in obese individuals with not changed insulin sensitivity, but strong increased in obese adolescents with insulin resistance as compared to relative healthy control individuals and to obese subjects without signs of insulin resistance (+232% and +197%, correspondingly; p<0.001). At the same time, the level of cortisol as well as fasting glucose did not change significantly in both groups of obese adolescents regardless of the presence of insulin resistance as compared to control (Table 1) . However, 2 h oral glucose tolerance test (OGTT) was significantly higher (+29%; p<0.05) only in the group of obese adolescents with insulin resistance as compared to control individuals (Table 1) . RNA isolation. Trisol reagent (Invitrogen, USA) was used for RNA extraction from the blood of healthy adolescents (without signs of obesity) as control and obese individuals with or without insulin resistance as described previously (Minchenko et al. 2004 ). The RNA pellets were washed with 75% ethanol and dissolved in ribonuclease-free water. For additional purification RNA samples were re-precipitated with 95% ethanol and re-dissolved in ribonuclease-free water. The concentration of RNA as well as its spectral characteristics was measured using NanoDrop Spectrophotometer ND1000 (PEQLAB, Biotechnologie GmbH).
Reverse transcription and quantitative realtime polymerase chain reaction analysis. The expression levels of genes related to the regulation of immune response (HLA-DRA, HLA-DRB1, HLA-F, HLA-G, and NFX1) as well as microRNA miR-190b as a potential regulator of HLA-DRA mRNA level were measured in blood by highly reproducible real-time quantitative polymerase chain reaction of cDNA (complementary DNA) (Cajander et al. 2016; Minchenko et al. 2018) . Polymerase chain reaction was performed in triplicates. The "QuantStudio 5 Real-Time PCR System" (Applied Biosystems), Absolute QPCR SYBRGreen Mix (Thermo Scientific, UK) and pair of primers specific for each studied gene (Sigma-Aldrich, USA) was used for quantitative polymerase chain reaction (Table 2 ). For polyadenylation and reverse transcription of miRNAs we used NCode™ miRNA First-Strand cDNA Synthesis Kit MIRC-10 (Invitrogen, USA) with specific reverse primer included in this Kit. The level of microRNA miR-190b was measured by real-time qPCR using SYBR GreenER™ qPCR SuperMix Universal (Invitrogen) and specific for this microRNA forward primer ( Table 2) .
The expression of beta-actin mRNA was used as control of analyzed RNA quantity. The amplified DNA fragments were analyzed on a 2% agarose gel and that visualized by 5x Sight DNA Stain (EURO-MEDEA). An analysis of quantitative PCR was performed using special computer program "Differential expression calculator".
Statistical analysis. Statistical analyses were performed according to Student's t-test using OriginPro 7.5 software (Bochkov et al. 2006) . All values are expressed as mean±SEM from seven independent experiments; p<0.05 was considered as significant difference.
Results
We analyzed the expression of a subset of genes encoding HLA-DRA, HLA-DRB1, HLA-F, HLA-G, and NFX1 proteins, which play a central role in the immune system by presenting peptides derived from extracellular proteins and also associate with cell proliferation, in the blood of three groups of adolescents: relative healthy (control) participants, obese boys without signs of insulin resistance and obese individuals with insulin resistance using quantitative polymerase chain reaction. As shown in Figure 1 , the expression level of HLA-DRA gene in the blood of obese adolescents with not changed sensitivity to insulin is increased (+21%; p<0.05) as compared to control group. At the same time, the expression level of this gene is significantly down-regulated in obese adolescents with insulin resistance as compared both to control group (-91%; p<0.001) and group of obese adolescents with not changed sensitivity to insulin (-93%; p<0.001) (Figure 1) . Therefore, development of insulin resistance in obese adolescents strongly suppressed the expression of HLA-DRA gene in the blood. The HLA-DRB1 gene encodes the beta1 subunits of HLA-DR receptor and its expression in obese adolescents was similar to HLA-DRA gene both in group without signs of insulin resistance and with insulin resistance (Figure 2) . Thus, the expression level of HLA-DRB1 gene is increased in the blood of obese individuals with not changed sensitivity to insulin (+23%; p<0.05) as compared to the group of healthy control adolescents. We have also shown that the development of insulin resistance in obese individuals leads to strong down-regulation of HLA-DRB1 gene expression in the blood: -90% (p<0.001) as compared to control adolescents and -92% (p<0.001) as compared to the group of obese individuals without signs of insulin resistance (Figure 2 ). Therefore, development of insulin resistance in obese adolescents strongly suppressed the expression of HLA-DRB1 gene like HLA-DRA gene, encoding protein-partner for heterodimeric HLA-DR receptor. We also found that development of obesity with not changed sensitivity to insulin leads to downregulation of the expression of HLA-G gene in the blood (-40%; p<0.01) as compared to control group of adolescents (Figure 3 ). More strong changes in this gene expression were observed in obese individuals with impaired sensitivity to insulin: -72% (p<0.001) adolescents and -53% (p<0.001) as compared to the group of obese individuals without sign of insulin resistance (Figure 3) . Therefore, the expression of HLA-G, which is a non-classical HLA-class I molecule, is down-regulated in the blood of obese adolescents but development of insulin resistance in obese adolescents leads to more strongly suppression of this gene expression. As shown in Figure 4 , the expression level of gene encoding HLA-F, which is a non-classical HLA-class I molecule with immunosuppressive properties, does not changed significantly in obese adolescents without sign of insulin resistance, but development of insulin resistance in obese adolescent leads to strong down-regulation of this gene expression in the blood: -89% (p<0.001) as compared to control individuals and -88% (p<0.001) as compared to the group of obese adolescents without sign of insulin resistance. Thus, the development of insulin resistance in obese adolescents strongly suppresses the expression level of HLA-F gene; meanwhile obesity does not affect its expression.
Next, we investigated the expression level of NFX1 mRNA in the blood of obese adolescents with not changed sensitivity to insulin and with insulin resistance, because NFX1 is a transcriptional repressor, which sequence-specifically interacts with the conserved X1 box regulatory element found in the proximal promoter of major histocompatibility complex (MHC) class II genes and regulates their expression (Song et al. 1994) . As shown in Figure 5 , the expression level of this gene does not change significantly in the group of obese individuals without signs of insulin resistance as compared to control group of adolescents. However, in obese individuals with impaired sensitivity to insulin we observed up-regulation of this gene expression (+17% (p<0.05) as compared to healthy control subjects and more significant changes in the expression of NFX1 gene (+29%; p<0.05) as compared to the group of obese individuals without signs of insulin resistance ( Figure 5) . Therefore, the expression of NFX1, which is a transcriptional repressor, is up-regulated in the blood of obese adolescents with insulin resistance and possibly participates in strong suppression of HLA-DRA gene expression in the blood of obese adolescents with insulin resistance.
We have also studied the expression level of microRNA miR-190b because in 3'-region of HLA-DRA mRNA we identified specific binding site of this microRNA by bioinformatics analysis (http://www.targetscan.org/vert_50/). As shown in Figure 4 . Expression of major histocompatibility complex, class I, F (HLA-F) mRNA in blood of obese individuals with normal insulin sensitivity (Obesity) and obese patients with insulin resistance (Obesity + IR) as well as in normal adolescents (Control). The values of this mRNA expression was normalized to the expression of beta-actin mRNA, expressed as mean±SEM and represented as a percent of control (100 %); n=7. (miR190b) in blood of obese individuals without insulin resistance (Obesity) and obese patients with resistance to insulin (Obesity + IR) as well as in normal adolescents (Control) . The values of this miRNA expression were normalized to the expression of beta-actin mRNA, expressed as mean±SEM and represented as a percent of control (100%); n=7. Figure 6 , the level of miR-190b is decreased in the blood of obese adolescents with not changed sensitivity to insulin (-34%; p<0.01). At the same time, development of insulin resistance leads to reversible changes in this microRNA expression: +53% (p<0.01) as compared to control group of healthy individuals and +132% (p<0.001) as compared to the group of obese adolescents without signs of insulin resistance (Figure 6) . Thus, the changes in miR-190b possibly contribute both in up-regulation of HLA-DRA gene expression in the blood of obese adolescents without signs of insulin resistance and in strong suppression of this gene expression in subjects with obesity complicated by insulin resistance.
Discussion
Results of this investigation clearly demonstrated that obesity affects the expression level of most studied immune response related genes in genespecific manner in the blood and that these changes are insulin sensitive because development of insulin resistance in obese individuals significantly modifies these genes expression levels (Figure 7 ). Thus, the expression level of HLA-DRA and HLA-DRB1 genes is increased in obese adolescents and these results agree well with data Nair et al. (2005) that obesity upregulates HLA-DRA expression. However, development of insulin resistance in obese individuals strongly suppressed the expression of both HLA-DRA and HLA-DRB1 genes. These results indicate that these genes expression is very sensitive to the efficiency of insulin action. The changes in the expression of both HLA-DRA and HLA-DRB1 genes are similar in obese adolescents without signs of insulin resistance as well as with insulin resistance. This similarity can be explained their co-regulated expression, which is mediated by the MHCII RNA operon (Song et al. 1994; Pisapia et al. 2013) . It is possible, at least in part, that upregulation of the expression of HLA-DRA gene in the blood of obese adolescents is associated with down-regulation of miR-190b, which has specific binding sites on 3'-untranslated region of HLA-DRA mRNA. Furthermore, down-regulation of HLA-DRA gene expression in obese subjects with insulin resistance possibly associated, at least in part, with up-regulation of transcription repressor NFX1 as well as significant increase of microRNA miR- 190b. These results agree well with data Song et al. (1994) because down-regulation of HLA-DRA gene expression is associated with up-regulation of transcription repressor NFX1. It is interesting to note that the RTA (replication and transcription activator) encoded by Kaposi's sarcoma-associated herpesvirus can function as an E3 ligase to degrade HLA-DRA by direct binding to HLA-DRA and inducing its degradation of through the ubiquitin-proteasome degradation pathway (Sun et al. 2016) .
At the same time, the expression level of nonclassical HLA-class I molecule G (HLA-G) is downregulated in childhood obesity and in obese adolescents with insulin resistance these changes were more significant. Recently, it was shown that there is a strong association between HLA-G 14 bp ins/ins genotype and insulin resistance in obese children and adolescents (Marzuillo et al. 2018 ), but at the same time, there were identified two opposite sides of HLA-G function: beneficial to be promoted or deleterious to be blocked (Amiot et al. 2015; Carosella et al. 2015) . Thus, additional studies may be necessary to determine the functional significance of HLA-G gene expression in obese subjects both with and without insulin resistance.
Next, we have shown that the expression of other representative of non-classical HLA-class I molecules, HLA-F, is down-regulated in obese adolescents only after development of insulin resistance. It is possible that HLA-F gene expression is very sensitive to the effectiveness of insulin action. At the same time, we could not exclude other mechanisms of strong downregulation of this gene expression in obesity associated insulin resistance. It is interesting to note that the overexpression of HLA-F in islet cells is a hallmark in the immunopathogenesis of type 1 diabetes (Richardson et al. 2016) . It is possible that HLA-F has additional function because these are also findings that HLA-F expression is correlated with tumor cell invasion and metastasis Martinez-Canales et al. 2017; Wu et al. 2018) . Thus, the functional significance of insulin resistance associated changes in the expression of HLA-F gene, as a non-classical HLA-class I molecule with immunosuppressive properties, remains unclear and deserves further investigation.
The development of obesity as well as its metabolic complications is associated with dysregulation of numerous intrinsic mechanisms, which control most key metabolic processes, including cellular growth, glucose and lipid metabolism as well as insulin sensitivity and immune response (Ruderman et al. 2013; Lee and Ozcan 2014; Leite et al. 2014; Tam et al. 2017; Wu et al. 2017) . It is possible that changes in classical HLA-class II molecules and non-classical HLA-class I molecules, which we observed in childhood obesity with and without insulin resistance, can contribute to these numerous intrinsic mechanisms of glucose and lipid metabolism dysregulation as well as cellular growth, because HLA-DR receptor and non-classical HLA-class I molecules play an important role in the regulation of both immune response and proliferative processes and participate in endoplasmic reticulum stress, an important factor of insulin resistance and obesity (Schaiff et al. 1992; Minchenko et al. 2005; Yuzefovych et al. 2013; Han and Kaufman 2014; Lee and Ozcan 2014; Carosella et al. 2015; Walentowicz-Sadlecka et al. 2018; Yang et al. 2018) . Furthermore, there is data that both HLA-DR receptor and non-classical HLA-class I molecules play an important role in tumorigenesis (Kochan et al. 2013; Morandi et al. 2013; Leite et al. 2014; Zeestraten et al. 2014; Harada et al. 2015; Ishigami et al. 2015; Brown et al. 2016; Martinez-Canales et al. 2017; Winkler et al. 2017; Walentowicz-Sadlecka et al. 2018; Wu et al. 2018) . It is interesting to note that the absent in melanoma 2 (AIM2), which is a member of the IFN-inducible nuclear proteins, associated with both infection defense and tumor pathology, mediates induction of several interferon-stimulated genes, including genes encoding the major histocompatibility complex class II antigens HLA-DRA and HLA-DRB in cancer cells (Kochan et al. 2013) . In this study, we have shown that obesity down-regulates the expression of miR190b but development of insulin resistance in obese adolescents leads to significant up-regulation of this microRNA level, which possibly contributes to strong down-regulation of HLA-DRA as well as in many other processes, because there is data that miR190b is significantly up-regulated in breast tumors (Cizeron-Clairac et al. 2015) . These data completely agree with our results, which demonstrated possible mechanism connecting obesity with tumorigenesis as well as with data Tsuchihara et al. (2008) .
Taking into account the importance of the major histocompatibility complex class II and class I antigen functions, we suggest that down-regulation of the expression levels of HLA-DRA, HLA-DRB1, HLA-G, and HLA-F as well as up-regulation of miR-190b mediated by insulin resistance associated with obesity may contribute to the dysregulation of immune response as well as to the risk of tumorigenesis. Therefore, it is possible that most obesity and insulin related changes in the expression of the major histocompatibility complex class II and class I antigen genes are mediated through endoplasmic reticulum stress, although detailed molecular mechanisms cannot be ruled out.
We hope that identification of real mechanisms of metabolic abnormalities in obesity as well as its complications at molecular and cellular levels helps to better understanding why obesity develops and why only a part of the obese individuals develops secondary metabolic disorders including insulin resistance and dysregulation of immune response. However, a detailed molecular mechanism of the involvement of different genes of regulatory network in the development of obesity and its complications are not clear yet and remains to be determined.
